AIHA-Event-Banner.jpg
Line separator

Advocate
 

Save the date, and share your story at a drug development meeting on autoimmune hepatitis on Friday, January 27, 2023.

Join Us!

Mark your calendars and plan to join us for a Virtual Externally-Led Patient Focused Drug Development Meeting (EL-PFDD) on autoimmune hepatitis on Friday, January 27, 2023 at 10 a.m. ET. 

female-caucasian-speaker-giving-presentation-in-ha-2022-02-02-04-49-41-utc-SFW.jpg
Externally-Led Patient Focused Drug Development Meeting (EL-PFDD) on Autoimmune Hepatitis

Friday, January 27, 2023 
10 a.m.-2:30 p.m. ET

Virtual Event

Mark Your Calendars

Join us for an Externally-Led Patient Focused Drug Development Meeting (EL-PFDD) on Autoimmune Hepatitis on Friday, January 27, 2023 beginning at 10 a.m. ET. The event is being held virtually. Register here. Patients and caregivers, please be sure to fill out our pre-event survey

 

Open To Everyone

The meeting, which is being hosted by the Autoimmune Hepatitis Association, is open to all. 

 

The Overall Goal

The goal of the meeting is to provide the U.S. Food and Drug Administration (FDA), drug developers, doctors, and academic researchers opportunities to hear from AIH patients about the impact the disease has on their health and daily life. It’s also a chance for patients to share their views of currently available therapies and goals for treatment. 

 

The AIHA hopes this important meeting will shine a light on the need for new treatments that work for all patients and that have fewer side effects. 
 

We’ve been working hard to plan this meeting with the help of the FDA, and we need as many patients as possible to attend.